One Capital Management LLC Sells 10,290 Shares of Koninklijke Philips (NYSE:PHG)

One Capital Management LLC decreased its position in Koninklijke Philips (NYSE:PHG) by 3.4% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 288,043 shares of the technology company’s stock after selling 10,290 shares during the quarter. One Capital Management LLC’s holdings in Koninklijke Philips were worth $7,259,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in PHG. Mondrian Investment Partners LTD grew its holdings in shares of Koninklijke Philips by 45.1% in the 1st quarter. Mondrian Investment Partners LTD now owns 9,553,058 shares of the technology company’s stock worth $191,061,000 after purchasing an additional 2,971,008 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in Koninklijke Philips by 27.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 4,036,336 shares of the technology company’s stock worth $101,718,000 after acquiring an additional 864,951 shares during the last quarter. Jane Street Group LLC grew its holdings in Koninklijke Philips by 361.7% during the 1st quarter. Jane Street Group LLC now owns 629,136 shares of the technology company’s stock worth $12,583,000 after acquiring an additional 492,881 shares during the last quarter. Brandes Investment Partners LP grew its holdings in Koninklijke Philips by 48.7% during the 4th quarter. Brandes Investment Partners LP now owns 1,285,935 shares of the technology company’s stock worth $30,001,000 after acquiring an additional 421,055 shares during the last quarter. Finally, Russell Investments Group Ltd. grew its holdings in Koninklijke Philips by 36.4% during the 1st quarter. Russell Investments Group Ltd. now owns 1,410,067 shares of the technology company’s stock worth $28,201,000 after acquiring an additional 376,244 shares during the last quarter. Institutional investors own 13.67% of the company’s stock.

Koninklijke Philips Stock Down 0.1 %

Shares of NYSE:PHG opened at $30.74 on Monday. Koninklijke Philips has a one year low of $17.75 and a one year high of $30.91. The company has a 50 day moving average of $28.44 and a 200-day moving average of $25.40. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.16 and a quick ratio of 0.74. The stock has a market cap of $28.89 billion, a price-to-earnings ratio of -32.02, a P/E/G ratio of 1.05 and a beta of 0.73.

Koninklijke Philips (NYSE:PHG) last issued its quarterly earnings results on Monday, July 29th. The technology company reported $0.32 EPS for the quarter. Koninklijke Philips had a negative net margin of 2.35% and a positive return on equity of 10.15%. The company had revenue of $4.80 billion during the quarter. On average, sell-side analysts forecast that Koninklijke Philips will post 1.5 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised shares of Koninklijke Philips from a “hold” rating to a “buy” rating in a report on Monday, July 15th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat, Koninklijke Philips has a consensus rating of “Hold”.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.